指南与共识泌尿生殖MR

局灶治疗后前列腺MRI评估的跨大西洋建议(TARGET)与局灶消融后前列腺影像(PI-FAB)检测复发性前列腺癌的比较

Comparison of Transatlantic Recommendations for Prostate Gland Evaluation with MRI after Focal Therapy (TARGET) and Prostate Imaging after Focal Ablation (PI-FAB) for Detecting Recurrent Prostate Cancer at Prostate MRI.
指南 / 共识 · Acad Radiol · 2024-10-19

本回顾性研究纳入38例接受局灶治疗(FT)的局限性前列腺癌患者,比较TARGET与PI-FAB两种MRI解读系统检测复发性临床显著前列腺癌(csPCa)的诊断性能。14例存在复发csPCa;PI-FAB两阅片者敏感度均为92.9%、特异度分别为62.5%和54.2%,TARGET敏感度分别为78.6%和92.9%、特异度分别为79.2%和62.5%,两系统阅片者间一致性均为中等(κ=0.56和0.57)。

要点

  • PI-FAB两阅片者敏感度均92.9%,特异度分别为62.5%和54.2%,阴性预测值分别为93.8%和92.9%。
  • TARGET敏感度分别为78.6%和92.9%,特异度分别为79.2%和62.5%。
  • 两系统阅片者间一致性均为中等(PI-FAB κ=0.56,TARGET κ=0.57)。

核心结论

  • PI-FAB与TARGET在局灶治疗后MRI中表现相似;PI-FAB敏感度持续较高,TARGET对一位阅片者特异度更高,中等一致性水平表明两系统在临床环境中可行并有改进空间。

研究设计与样本

  • 回顾性研究,纳入38例因局限性前列腺癌接受初次局灶治疗并有随访多参数MRI(mpMRI)和活检的患者,由两名放射科医生独立使用PI-FAB和TARGET评估mpMRI,计算诊断性能指标和受试者工作特征曲线下面积(AUC),采用Cohen's κ和Kendall's τ评估阅片者间和阅片者内一致性。

诊断标准与关键数值

  • PI-FAB:敏感度两阅片者均为92.9%,特异度阅片者1为62.5%、阅片者2为54.2%,阴性预测值阅片者1为93.8%、阅片者2为92.9%。
  • TARGET:敏感度阅片者1为78.6%、阅片者2为92.9%,特异度阅片者1为79.2%、阅片者2为62.5%。
  • 阅片者间一致性:PI-FAB κ=0.56,TARGET κ=0.57。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The increasing use of focal therapy (FT) in localized prostate cancer (PCa) management requires a standardized MRI interpretation system to detect recurrent clinically significant PCa (csPCa). This pilot study evaluates the novel Transatlantic Recommendations for Prostate Gland Evaluation with MRI after Focal Therapy (TARGET) and compares its performance to that of the Prostate Imaging after Focal Ablation (PI-FAB) system.

MATERIALS AND METHODS: This retrospective study included 38 patients who underwent primary FT for localized PCa, with follow-up multiparametric MRI (mpMRI) and biopsy. Two radiologists assessed the mpMRIs using both PI-FAB and TARGET independently. Diagnostic performance metrics and area under the receiver operating characteristic curve (AUC) were calculated. Inter-reader and intrareader agreement were assessed using Cohen's κ and Kendall's τ.

RESULTS: 14 patients had recurrent csPCa. PI-FAB showed high sensitivity (92.9% for both readers) and NPV (reader 1: 93.8%, reader 2: 92.9%) but moderate specificity (reader 1: 62.5%, reader 2: 54.2%). TARGET demonstrated lower sensitivity for one reader (reader 1: 78.6%, reader 2: 92.9%) but higher specificity (reader 1: 79.2%, reader 2: 62.5%) for both readers. Both systems displayed moderate inter-reader agreement (κ = 0.56 for PI-FAB, 0.57 for TARGET).

CONCLUSION: PI-FAB and TARGET exhibit similar performances in post-FT MRI. While PI-FAB had consistently high sensitivity, TARGET offered higher specificity for one reader. Moderate agreement levels demonstrate the viability of these systems in clinical settings and a promise for improvement.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Esengur OT, Gelikman DG, Law YM, et al. Comparison of Transatlantic Recommendations for Prostate Gland Evaluation with MRI after Focal Therapy (TARGET) and Prostate Imaging after Focal Ablation (PI-FAB) for Detecting Recurrent Prostate Cancer at Prostate MRI. Acad Radiol. 2024. PMID: 39426916. doi:10.1016/j.acra.2024.09.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。